Wednesday, March 19, 2014 1:27:55 AM
SK3 owns the Co from a stock swap.
SK3 merge with AEGY that SK3 owns anyway.
AVNE from the stock swap gets: Aventura receiving the rights to the intellectual property in the proprietary technology, processes, formulations, and marks of Berkeley Bio that have already been developed,
So SK3 owns all the stuff anyway, meaning it can figure who gets how much money from what.
If SK3 thinks having AVNE showing income from proprietary technology, processes, formulations, and marks of Berkeley Bio that have already been developed, then the stock has value. If SK3 says no value thetre then why the foward split and ticker?
on sale. Buy when when everyone else is selling.
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM